Cardiogen (20mg)

Cardiogen (20mg) – Research Peptide

Sequence: H-Ala-Glu-Asp-Arg-OH (AEDR)

Molecular Formula: C18H31N7O9 | Molecular Weight: 489.5 g/mol

Cardiogen is a synthetic tetrapeptide for research purposes. The science points to a primary mechanism focused on myocardial tissue. Studies suggest it may support cardiomyocyte proliferation and inhibit apoptosis (cell death) in cardiac cells, potentially by reducing p53 protein expression. This action is thought to influence cardiac remodeling and fibroblast activity.

Research models indicate potential applications in studies related to heart failure, angina, hypertrophy, and post-injury recovery. Observations note a protective effect on mitochondria and cellular energy (glycogen) preservation in cardiac tissue. Notably, some data suggests a contrasting, pro-apoptotic effect on certain tumor cell lines, indicating a complex, tissue-specific mechanism.

In the lab, it’s shown to penetrate cell nuclei and may activate synthesis of key structural proteins like actin, vimentin, and lamin. This is for controlled laboratory analysis only.

Key Research Points:

• May stimulate cardiomyocyte proliferation.
• Hypothesized to inhibit myocardial cell apoptosis.
• Shown to penetrate cytoplasm and nucleus in studies.
• Research indicates potential protective role in cardiac injury models.

Important Notice: This product is for research use in a laboratory setting only. It is NOT for human or animal consumption. It is a tool for licensed professionals.